Astrazeneca Phar

{
  "main_header": {
    "sid": 777011,
    "name": "Astrazeneca Phar",
    "stock_name": "Astrazeneca Phar",
    "full_name": "Astrazeneca Pharma India Ltd",
    "name_url": "stocks-analysis/astrazeneca-phar",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "8,090.00",
    "chg": -101,
    "chgp": "-1.23%",
    "dir": -1,
    "prev_price": "8,191.00",
    "mcapval": "20,551.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 506820,
    "symbol": "ASTRAZEN",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE203A01020",
    "curr_date": "Aug 10, 03:30 PM",
    "curr_time": "18:38 PM",
    "last_traded_at": "Aug 10, 03:30 PM IST",
    "bse_nse_vol": "49.24 k",
    "exc_status": "Active",
    "traded_date": "Aug 10, 2026",
    "traded_date_str": "2026 08 10",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/astrazeneca-phar-777011-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downturn",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-bearish-momentum-amid-technical-downturn-4137033",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AstrazenecaPhar_technicaldot_4137033.png",
        "date": "2026-08-05 08:04:48",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating by MarketsMOJO reflects growing concerns over its price action and technical health amid a challenging market environment for pharmaceuticals and biotechnology small-caps."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-technical-momentum-shifts-amid-mixed-market-signals-4134927",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AstrazenecaPhar_technicaldot_4134927.png",
        "date": "2026-08-04 08:07:11",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of early 2026. Despite a 2.37% gain on 4 Aug 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum measures. This analysis delves into the evolving technical landscape of this small-cap pharmaceutical player, contextualising its recent price action and longer-term trends against sector and benchmark indices."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4132366",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AstrazenecaPhar_mojoScore_4132366.png",
        "date": "2026-08-02 10:10:16",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 02 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4115151",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AstrazenecaPhar_mojoScore_4115151.png",
        "date": "2026-07-22 10:10:03",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 July 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4097003",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AstrazenecaPhar_mojoScore_4097003.png",
        "date": "2026-07-11 10:10:18",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 11 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4078812",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_mojoScore_4078812.png",
        "date": "2026-06-30 10:10:31",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/astrazeneca-pharma-india-ltd-faces-bearish-momentum-amid-technical-downgrade-4077911",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_technicaldot_4077911.png",
        "date": "2026-06-30 08:05:54",
        "description": "Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and momentum oscillators, suggests increasing downside pressure amid a challenging market environment for the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4063132",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_mojoScore_4063132.png",
        "date": "2026-06-19 10:10:57",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 June 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance."
      },
      {
        "title": "Astrazeneca Pharma India Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/astrazeneca-pharma-india-ltd-is-rated-sell-4037395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/AstrazenecaPhar_mojoScore_4037395.png",
        "date": "2026-06-08 10:10:23",
        "description": "Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing."
      }
    ],
    "total": 379,
    "sid": "777011",
    "stock_news_url": "https://www.marketsmojo.com/news/astrazeneca-pharma-india-777011"
  },
  "announcements": [
    {
      "details": "AstraZeneca Pharma India Limited has informed the Exchange regarding Analysts/Institutional Investor Meet/Con. Call Updates",
      "source": "NSE",
      "caption": "AstraZeneca Pharma India Limited - Analysts/Institutional Investor Meet/Con. Call Updates",
      "datetime": "05-Dec-2019"
    },
    {
      "details": "AstraZeneca Pharma India Limited has informed the Exchange a copy of disclosure of Related Party Transactions for half year ended September 30, 2019 under Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended",
      "source": "NSE",
      "caption": "AstraZeneca Pharma India Limited - Other General Purpose",
      "datetime": "27-Nov-2019"
    },
    {
      "details": "AstraZeneca Pharma India Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on November 13, 2019 in respect of the Unaudited Financial Results for the quarter ended September 30, 2019 approved in the Board Meeting of the Company held on November 11, 2019. '.",
      "source": "NSE",
      "caption": "AstraZeneca Pharma India Limited - Updates",
      "datetime": "15-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(10 Aug 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has declared <strong>1800%</strong> dividend, ex-date: 31 Jul 26",
          "dt": "2026-07-31",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Astrazeneca Pharma India Ltd has announced <strong>2:10</strong> stock split, ex-date: 15 Jun 06",
          "dt": "2006-06-15",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downturn

2026-08-05 08:04:48

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent downgrade from a Hold to a Sell rating by MarketsMOJO reflects growing concerns over its price action and technical health amid a challenging market environment for pharmaceuticals and biotechnology small-caps.

Read full news article

Astrazeneca Pharma India Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-08-04 08:07:11

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook as of early 2026. Despite a 2.37% gain on 4 Aug 2026, the stock’s technical indicators present a complex picture, with mixed signals from MACD, RSI, moving averages, and other momentum measures. This analysis delves into the evolving technical landscape of this small-cap pharmaceutical player, contextualising its recent price action and longer-term trends against sector and benchmark indices.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-08-02 10:10:16

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 02 August 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-07-22 10:10:03

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO. This rating was last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 22 July 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-07-11 10:10:18

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 11 July 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-06-30 10:10:31

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 30 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Astrazeneca Pharma India Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-06-30 08:05:54

Astrazeneca Pharma India Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The stock’s recent price action, combined with deteriorating moving averages and momentum oscillators, suggests increasing downside pressure amid a challenging market environment for the Pharmaceuticals & Biotechnology sector.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-06-19 10:10:57

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 19 June 2026, providing investors with an up-to-date view of its fundamentals, returns, and market performance.

Read full news article

Astrazeneca Pharma India Ltd is Rated Sell

2026-06-08 10:10:23

Astrazeneca Pharma India Ltd is rated Sell by MarketsMOJO, with this rating last updated on 02 January 2026. However, the analysis and financial metrics presented here reflect the stock’s current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

View All News